Healthcare provider profile · identity verified

Joyce E. Bumgardner, FNP

Nurse Practitioner · LINCOLNTON, NC · NPI 1336572064

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	685	160
Omeprazole	Omeprazole	538	123
Amlodipine Besylate	Amlodipine Besylate	485	114
Gabapentin	Gabapentin	445	89
Lisinopril	Lisinopril	434	114
Levothyroxine Sodium	Levothyroxine Sodium	408	94
Losartan Potassium	Losartan Potassium	343	77
Metoprolol Succinate	Metoprolol Succinate	313	76
Metformin Hcl	Metformin Hcl	260	58
Albuterol Sulfate Hfa	Albuterol Sulfate	247	72
Trazodone Hcl	Trazodone Hcl	222	55
Pantoprazole Sodium	Pantoprazole Sodium	217	49
Metformin Hcl Er	Metformin Hcl	213	51
Montelukast Sodium	Montelukast Sodium	185	37
Fluticasone Propionate	Fluticasone Propionate	182	53
Tizanidine Hcl	Tizanidine Hcl	181	49
Rosuvastatin Calcium	Rosuvastatin Calcium	172	48
Furosemide	Furosemide	164	45
Famotidine	Famotidine	162	34
Sertraline Hcl	Sertraline Hcl	159	47
Duloxetine Hcl	Duloxetine Hcl	149	33
Meloxicam	Meloxicam	147	37
Escitalopram Oxalate	Escitalopram Oxalate	146	28
Ozempic	Semaglutide	146	32
Buspirone Hcl	Buspirone Hcl	145	30
Jardiance	Empagliflozin	139	24
Hydrochlorothiazide	Hydrochlorothiazide	138	36
Pravastatin Sodium	Pravastatin Sodium	134	30
Simvastatin	Simvastatin	127	33
Carvedilol	Carvedilol	114	28
Tamsulosin Hcl	Tamsulosin Hcl	114	31
Eliquis	Apixaban	105	19
Oxybutynin Chloride Er	Oxybutynin Chloride	104	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	31
Potassium Chloride	Potassium Chloride	102	18
Glipizide Er	Glipizide	101	26
Tramadol Hcl	Tramadol Hcl	98	20
Allopurinol	Allopurinol	93	23
Bupropion Xl	Bupropion Hcl	91	21
Pioglitazone Hcl	Pioglitazone Hcl	89	23
Metoprolol Tartrate	Metoprolol Tartrate	88	21
Clopidogrel	Clopidogrel Bisulfate	85	22
Farxiga	Dapagliflozin Propanediol	81	15
Trulicity	Dulaglutide	81	14
Ezetimibe	Ezetimibe	75	11
Fluoxetine Hcl	Fluoxetine Hcl	69	19
Celecoxib	Celecoxib	68	16
Lorazepam	Lorazepam	68	14
Diclofenac Sodium	Diclofenac Sodium	67	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	16
Esomeprazole Magnesium	Esomeprazole Magnesium	62	15
Amitriptyline Hcl	Amitriptyline Hcl	58	12
Ropinirole Hcl	Ropinirole Hcl	57	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	17
Triamcinolone Acetonide	Triamcinolone Acetonide	56	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	suppressed
Nifedipine Er	Nifedipine	54	18
Glimepiride	Glimepiride	50	16
Mounjaro	Tirzepatide	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Clonidine Hcl	Clonidine Hcl	48	11
Spironolactone	Spironolactone	48	13
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Atenolol	Atenolol	42	suppressed
Amoxicillin	Amoxicillin	41	37
Ondansetron Hcl	Ondansetron Hcl	41	13
Synthroid	Levothyroxine Sodium	40	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	38	11
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Temazepam	Temazepam	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	34	30
Finasteride	Finasteride	34	13
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Valsartan	Valsartan	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	12
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Roflumilast	Roflumilast	31	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Cephalexin	Cephalexin	30	22
Clobetasol Propionate	Clobetasol Propionate	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	12
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	25	suppressed
Methimazole	Methimazole	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Sucralfate	Sucralfate	23	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Fluconazole	Fluconazole	22	14
Glipizide	Glipizide	22	suppressed
Linzess	Linaclotide	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Azithromycin	Azithromycin	20	17
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Nystatin	Nystatin	18	12
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Topiramate	Topiramate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Indapamide	Indapamide	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	16	suppressed
Baclofen	Baclofen	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Prednisone	Prednisone	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error